Discovery on Target

Erica Lovett, Research Scientist at AbCellera, will be presenting “Enduring solutions to the evolving COVID-19 crisis: Discovery of a potent human antibody that neutralizes SARS-CoV-2 and its variants” at Discovery on Target in the Antibodies Against Membrane Protein Targets – Part 2 session on September 29 at 5:55pm EST.